Inflammation in multiple sclerosis
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is characterised pathologically by demyelination, gliosis, neuro-axonal damage and inflammation. Despite intense research, the underlying pathomechanisms driving inflammatory demyelination in MS still remain incompletely understood. It is thought to be caused by an autoimmune response towards CNS self-antigens in genetically susceptible individuals, assuming autoreactive T cells as disease-initiating immune cells. Yet, B cells were recognized as crucial immune cells in disease pathology, including antibody-dependent and independent effects. Moreover, myeloid cells are important contributors to MS pathology, and it is becoming increasingly evident that different cell types act in concert during MS immunopathology. This is supported by the finding that the beneficial effects of actual existing disease-modifying therapies cannot be attributed to one single immune cell-type, but rather involve immunological cooperation. The current strategy of MS therapies thus aims to shift the immune cell repertoire from a pro-inflammatory towards an anti-inflammatory phenotype, involving regulatory T and B cells and anti-inflammatory macrophages. Although no existing therapy actually exists that directly induces an enhanced regulatory immune cell pool, numerous studies identified potential net effects on these cell types. This review gives a conceptual overview on T cells, B cells and myeloid cells in the immunopathology of relapsing-remitting MS and discusses potential contributions of actual disease-modifying therapies on these immune cell phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., & Geissmann, F. (2007) · Science · doi:10.1126/science.1142883 · Cited by 1,973
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Microglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
Developmental and Functional Heterogeneity of Monocytes
Guilliams, M., Mildner, A., & Yona, S. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.005 · Cited by 973
Immunologic Effects of Vitamin D on Human Health and Disease
Charoenngam, N., & Holick, M. F. (2020) · Nutrients · doi:10.3390/nu12072097 · Cited by 967
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Du Pasquier, R. A., Romero, P., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 933
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.007 · Cited by 927
Self-citationIdentification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Nr4a1-Dependent Ly6Clow Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal
Carlin, L. M., Stamatiades, E. G., Auffray, C., Hanna, R. N., Glover, L., Vizcay-Barrena, G., Hedrick, C. C., Cook, H. T., Diebold, S., & Geissmann, F. (2013) · Cell · doi:10.1016/j.cell.2013.03.010 · Cited by 768
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Panitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P., Bar-Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743
Comparison of gene expression profiles between human and mouse monocyte subsets
Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235028 · Cited by 729
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
The three human monocyte subsets: implications for health and disease
Wong, K. L., Yeap, W. H., Tai, J. J. Y., Ong, S. M., Dang, T. M., & Wong, S. C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8297-3 · Cited by 680
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Lassmann, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03116 · Cited by 663
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 644
Self-citationRegulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R., Poe, J. C., Leonard, W. J., & Tedder, T. F. (2012) · Nature · doi:10.1038/nature11501 · Cited by 634
Defective cholesterol clearance limits remyelination in the aged central nervous system
Cantuti-Castelvetri, L., Fitzner, D., Bosch-Queralt, M., Weil, M.-T., Su, M., Sen, P., Ruhwedel, T., Mitkovski, M., Trendelenburg, G., Lütjohann, D., et al. (2018) · Science · doi:10.1126/science.aan4183 · Cited by 586
Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology · doi:10.1002/ana.21748 · Cited by 551
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
Dominguez-Villar, M., Baecher-Allan, C. M., & Hafler, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2389 · Cited by 526
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Jelcic, I., Al Nimer, F., Wang, J., Lentsch, V., Planas, R., Jelcic, I., Madjovski, A., Ruhrmann, S., Faigle, W., Frauenknecht, K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.011 · Cited by 508
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Will the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
Li, R., Rezk, A., Miyazaki, Y., Hilgenberg, E., Touil, H., Shen, P., Moore, C. S., Michel, L., Althekair, F., Rajasekharan, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab4176 · Cited by 453
The Role of CD40 Ligand in Costimulation and T‐Cell Activation
Grewal, I. S., & Flavell, R. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00921.x · Cited by 449
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J., & Tolosa, E. (2009) · Brain · doi:10.1093/brain/awp289 · Cited by 431
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., & Weiner, H. L. (1986) · Annals of Neurology · doi:10.1002/ana.410190610 · Cited by 399
Modulation of inflammatory and immune responses by vitamin D
Colotta, F., Jansson, B., & Bonelli, F. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.007 · Cited by 399
Ando, D. G., Clayton, J., Kono, D., Urban, J. L., & Sercarz, E. E. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90117-2 · Cited by 391
Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
Henderson, A. P. D., Barnett, M. H., Parratt, J. D. E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21800 · Cited by 387
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15751 · Cited by 386
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
Rojas, O. L., Pröbstel, A.-K., Porfilio, E. A., Wang, A. A., Charabati, M., Sun, T., Lee, D. S. W., Galicia, G., Ramaglia, V., Ward, L. A., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.035 · Cited by 382
T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β
Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., & Novelli, F. (2009) · Annals of Neurology · doi:10.1002/ana.21652 · Cited by 375
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215751 · Cited by 346
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Srivastava, R., Aslam, M., Kalluri, S. R., Schirmer, L., Buck, D., Tackenberg, B., Rothhammer, V., Chan, A., Gold, R., Berthele, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110740 · Cited by 343
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90036-x · Cited by 315
Sites and Stages of Autoreactive B Cell Activation and Regulation
Shlomchik, M. J. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.004 · Cited by 312
Helminth infections associated with multiple sclerosis induce regulatory B cells
Correale, J., Farez, M., & Razzitte, G. (2008) · Annals of Neurology · doi:10.1002/ana.21438 · Cited by 311
Neuropathology in multiple sclerosis: new concepts
Lassmann, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400301 · Cited by 306
Zhang, G.-X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M., & Rostami, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2153 · Cited by 305
Toward a Refined Definition of Monocyte Subsets
Ziegler-Heitbrock, L., & Hofer, T. P. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00023 · Cited by 298
Cao, Y., Goods, B. A., Raddassi, K., Nepom, G. T., Kwok, W. W., Love, J. C., & Hafler, D. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8038 · Cited by 295
Childhood body mass index and multiple sclerosis risk: a long-term cohort study
Munger, K. L., Bentzen, J., Laursen, B., Stenager, E., Koch-Henriksen, N., Sørensen, T. I., & Baker, J. L. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513483889 · Cited by 293
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Palanichamy, A., Jahn, S., Nickles, D., Derstine, M., Abounasr, A., Hauser, S. L., Baranzini, S. E., Leppert, D., & von Büdingen, H.-C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400118 · Cited by 289
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
Pender, M. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.005 · Cited by 285
Hugh Perry, V (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00145-3 · Cited by 276
Hong, J., Li, N., Zhang, X., Zheng, B., & Zhang, J. Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502187102 · Cited by 264
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
Ray, A., Basu, S., Williams, C. B., Salzman, N. H., & Dittel, B. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103354 · Cited by 261
Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
Ascherio, A., & Munger, K. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9201-3 · Cited by 259
Villar, L. M., Sádaba, M. C., Roldán, E., Masjuan, J., González-Porqué, P., Villarrubia, N., Espiño, M., García-Trujillo, J. A., Bootello, A., & Álvarez-Cermeño, J. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522833 · Cited by 259
Kabat, E. A., Glusman, M., & Knaub, V. (1948) · The American Journal of Medicine · doi:10.1016/s0002-9343(48)90389-1 · Cited by 256
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
Huber, M., Heink, S., Pagenstecher, A., Reinhard, K., Ritter, J., Visekruna, A., Guralnik, A., Bollig, N., Jeltsch, K., Heinemann, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63681 · Cited by 254
Bielekova, B., Sung, M.-H., Kadom, N., Simon, R., McFarland, H., & Martin, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3893 · Cited by 241
Regulatory T cells in autoimmune neuroinflammation
Kleinewietfeld, M., & Hafler, D. A. (2014) · Immunological Reviews · doi:10.1111/imr.12169 · Cited by 230
Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis
Pröbstel, A.-K., Zhou, X., Baumann, R., Wischnewski, S., Kutza, M., Rojas, O. L., Sellrie, K., Bischof, A., Kim, K., Ramesh, A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc7191 · Cited by 228
Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
Genç, K., Dona, D. L., & Reder, A. T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119455 · Cited by 228
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Singh, S., Metz, I., Amor, S., van der Valk, P., Stadelmann, C., & Brück, W. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1082-0 · Cited by 211
Interferon-γ switches monocyte differentiation from dendritic cells to macrophages
Delneste, Y., Charbonnier, P., Herbault, N., Magistrelli, G., Caron, G., Bonnefoy, J.-Y., & Jeannin, P. (2003) · Blood · doi:10.1182/blood-2002-04-1164 · Cited by 210
Kim, H. J., Ifergan, I., Antel, J. P., Seguin, R., Duddy, M., Lapierre, Y., Jalili, F., & Bar-Or, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7144 · Cited by 200
Xiao, B.-G., Linington, C., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90014-x · Cited by 197
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Brändle, S. M., Obermeier, B., Senel, M., Bruder, J., Mentele, R., Khademi, M., Olsson, T., Tumani, H., Kristoferitsch, W., Lottspeich, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522730113 · Cited by 190
Kabat, E. A., Freedman, D. A., Murray, J. P., & Knaub, V. (1950) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195001000-00009 · Cited by 186
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Lisak, R. P., Benjamins, J. A., Nedelkoska, L., Barger, J. L., Ragheb, S., Fan, B., Ouamara, N., Johnson, T. A., Rajasekharan, S., & Bar-Or, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.015 · Cited by 180
Neuropathology of multiple sclerosis—new concepts
Kornek, B., & Lassmann, H. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00095-9 · Cited by 165
Specific peripheral B cell tolerance defects in patients with multiple sclerosis
Kinnunen, T., Chamberlain, N., Morbach, H., Cantaert, T., Lynch, M., Preston-Hurlburt, P., Herold, K. C., Hafler, D. A., O’Connor, K. C., & Meffre, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68775 · Cited by 164
Meffre, E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06347.x · Cited by 155
Depletion of functionally active CD20+ T cells by rituximab treatment
Wilk, E., Witte, T., Marquardt, N., Horváth, T., Kalippke, K., Scholz, K., Wilke, N., Schmidt, R. E., & Jacobs, R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24998 · Cited by 152
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
Groß, C. C., Schulte‐Mecklenbeck, A., Klinsing, S., Posevitz‐Fejfár, A., Wiendl, H., & Klotz, L. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000183 · Cited by 148
Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Gingele, S., Jacobus, T. L., Konen, F. F., Hümmert, M. W., Sühs, K., Schwenkenbecher, P., Ahlbrecht, J., Möhn, N., Müschen, L. H., Bönig, L., et al. (2018) · Cells · doi:10.3390/cells8010012 · Cited by 143
T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
Hellings, N., Bar�e, M., Verhoeven, C., D'hooghe, M. B., Medaer, R., Bernard, C. C. A., Raus, J., & Stinissen, P. (2001) · Journal of Neuroscience Research · Cited by 142
Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
Zhang, Z., Zhang, Z., Schittenhelm, J., Wu, Y., Meyermann, R., & Schluesener, H. J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.006 · Cited by 139
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
Lisak, R. P., Nedelkoska, L., Benjamins, J. A., Schalk, D. L., Bealmear, B., Touil, H., Li, R., Muirhead, G., & Bar‐Or, A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.004 · Cited by 139
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
von Essen, M. R., Ammitzbøll, C., Hansen, R. H., Petersen, E. R., McWilliam, O. H., Marquart, H. V., Damm, P., & Sellebjerg, F. T. (2018) · Brain · doi:10.1093/brain/awy301 · Cited by 138
Burger, D., Molnarfi, N., Weber, M. S., Brandt, K. J., Benkhoucha, M., Gruaz, L., Chofflon, M., Zamvil, S. S., & Lalive, P. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812183106 · Cited by 132
Monocytes in multiple sclerosis: phenotype and cytokine profile
Kouwenhoven, M. C. M., Teleshova, N., Özenci, V., Press, R., & Link, H. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00396-9 · Cited by 131
Han, S., Lin, Y. C., Wu, T., Salgado, A. D., Mexhitaj, I., Wuest, S. C., Romm, E., Ohayon, J., Goldbach-Mansky, R., Vanderver, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302884 · Cited by 127
Barnett, L. G., Simkins, H. M. A., Barnett, B. E., Korn, L. L., Johnson, A. L., Wherry, E. J., Wu, G. F., & Laufer, T. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301284 · Cited by 123
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis
Nicoletti, F., Patti, F., Cocuzza, C. E., Zaccone, P., Nicoletti, A. S. Q., Marco, R. D., & Reggio, A. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00101-4 · Cited by 123
Anti-CD20 therapy depletes activated myelin-specific CD8 + T cells in multiple sclerosis
Sabatino, J. J., Wilson, M. R., Calabresi, P. A., Hauser, S. L., Schneck, J. P., & Zamvil, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915309116 · Cited by 121
Contact with Central Nervous System Myelin Inhibits Oligodendrocyte Progenitor Maturation
Robinson, S., & Miller, R. H. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9466 · Cited by 120
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System
Waschbisch, A., Schröder, S., Schraudner, D., Sammet, L., Weksler, B., Melms, A., Pfeifenbring, S., Stadelmann, C., Schwab, S., & Linker, R. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501960 · Cited by 117
Self-citationCarstensen, M., Stilund, M., Petersen, T., Møller, H. J., Petersen, E. L., & Christensen, T. (2017) · Immunology and Cell Biology · doi:10.1111/imcb.1025 · Cited by 117
Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis
Chuluundorj, D., Harding, S. A., Abernethy, D., & La Flamme, A. C. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2014.15 · Cited by 116
Natalizumab: A new treatment for relapsing remitting multiple sclerosis
Hutchinson, M. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.2.259 · Cited by 112
Lückel, C., Picard, F., Raifer, H., Campos Carrascosa, L., Guralnik, A., Zhang, Y., Klein, M., Bittner, S., Steffen, F., Moos, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13731-z · Cited by 102
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 102
Chen, M., Chen, G., Deng, S., Liu, X., Hutton, G. J., & Hong, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.014 · Cited by 92
Blumenfeld, S., Staun-Ram, E., & Miller, A. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.03.012 · Cited by 91
The prognostic significance of cerebrospinal fluid in multiple sclerosis
Siritho, S., & Freedman, M. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.029 · Cited by 91
Wu, C., Rauch, U., Korpos, E., Song, J., Loser, K., Crocker, P. R., & Sorokin, L. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804247 · Cited by 90
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
Schubert, R. D., Hu, Y., Kumar, G., Szeto, S., Abraham, P., Winderl, J., Guthridge, J. M., Pardo, G., Dunn, J., Steinman, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402029 · Cited by 90
Nissimov, N., Hajiyeva, Z., Torke, S., Grondey, K., Brück, W., Häusser‐Kinzel, S., & Weber, M. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012249117 · Cited by 90
A Role for Intrathymic B Cells in the Generation of Natural Regulatory T Cells
Walters, S. N., Webster, K. E., Daley, S. R., & Grey, S. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302519 · Cited by 89
Ireland, S. J., Guzman, A. A., O’Brien, D. E., Hughes, S., Greenberg, B. M., Flores, A., Graves, D. F., Remington, G. M., Frohman, E. M., Davis, L. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1472 · Cited by 84
Villar, L. M., Casanova, B., Ouamara, N., Comabella, M., Jalili, F., Leppert, D., de Andrés, C., Izquierdo, G., Arroyo, R., Avşar, T., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24190 · Cited by 81
Waldburger, K. E., Hastings, R. C., Schaub, R. G., Goldman, S. J., & Leonard, J. P. (1996) · Europe PMC (PubMed Central) · Cited by 81
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
Wiendl, H., & Groß, C. C. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.95 · Cited by 78
Brennan, K. M., Galban‐Horcajo, F., Rinaldi, S., O’Leary, C., Goodyear, C. S., Kalna, G., Arthur, A. T., Elliot, C., Barnett, S., Linington, C., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.002 · Cited by 77
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
Kowarik, M. C., Grummel, V., Wemlinger, S. M., Buck, D., Weber, M. S., Berthele, A., & Hemmer, B. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7145-2 · Cited by 75
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Michell‐Robinson, M. A., Moore, C. S., Healy, L. M., Osso, L. A., Zorko, N., Grouza, V., Touil, H., Poliquin‐Lasnier, L., Trudelle, A., Giacomini, P. S., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.270 · Cited by 74
Pul, R., Moharregh-Khiabani, D., Škuljec, J., Skripuletz, T., Garde, N., Voß, E. V., & Stangel, M. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9248-1 · Cited by 71
Arellano, G., Acuña, E., Reyes, L. I., Ottum, P. A., De Sarno, P., Villarroel, L., Ciampi, E., Uribe-San Martín, R., Cárcamo, C., & Naves, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00753 · Cited by 70
Miyazaki, Y., Niino, M., Fukazawa, T., Takahashi, E., Nonaka, T., Amino, I., Tashiro, J., Minami, N., Fujiki, N., Doi, S., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.001 · Cited by 68
Bodhankar, S., Galipeau, D., Vandenbark, A. A., & Offner, H. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000143 · Cited by 67
Early administration of IL-12 suppresses EAE through induction of interferon-γ
Gran, B., Chu, N., Zhang, G., Yu, S., Li, Y., Chen, X., Kamoun, M., & Rostami, A. M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.019 · Cited by 62
Hikawa, N., & Takenaka, T. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02150231 · Cited by 62
Okada, Y., Ochi, H., Fujii, C., Hashi, Y., Hamatani, M., Ashida, S., Kawamura, K., Kusaka, H., Matsumoto, S., Nakagawa, M., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.011 · Cited by 61
Haschka, D., Tymoszuk, P., Bsteh, G., Petzer, V., Berek, K., Theurl, I., Berger, T., & Weiss, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00594 · Cited by 60
Makhlouf, K., Weiner, H. L., & Khoury, S. J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00371-x · Cited by 58
Pathologic correlates of the magnetization transfer ratio in multiple sclerosis
Moccia, M., van de Pavert, S., Eshaghi, A., Haider, L., Pichat, J., Yiannakas, M., Ourselin, S., Wang, Y., Wheeler-Kingshott, C., Thompson, A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010909 · Cited by 58
Kim, Y., Kim, G., Shin, H.-J., Hyun, J., Kim, S. H., Lee, E. J., & Kim, H. J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1334-y · Cited by 56
Intrathecal Inflammation in Progressive Multiple Sclerosis
Monaco, S., Nicholas, R. S., Reynolds, R., & Magliozzi, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218217 · Cited by 53
Sola, P., Mandrioli, J., Simone, A. M., Ferraro, D., Bedin, R., Annecca, R., Venneri, M. G., Nichelli, P., & Merelli, E. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510386996 · Cited by 52
Moccia, M., Capacchione, A., Lanzillo, R., Carbone, F., Micillo, T., Perna, F., Rosa, A. D., Carotenuto, A., Albero, R., Matarese, G., et al. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418819074 · Cited by 50
Pul, R., Morbiducci, F., Škuljec, J., Skripuletz, T., Singh, V., Diederichs, U., Garde, N., Voß, E. V., Trebst, C., & Stangel, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051867 · Cited by 49
Luessi, F., Kraus, S. H. P., Trinschek, B., Lerch, S., Ploen, R., Paterka, M., Roberg, T., Poisa-Beiro, L., Klotz, L., Wiendl, H., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574895 · Cited by 43
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis
Capasso, N., Nozzolillo, A., Scalia, G., Lanzillo, R., Carotenuto, A., Angelis, M. D., Petruzzo, M., Saccà, F., Russo, C. V., Morra, V. B., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102802 · Cited by 42
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review
Plemel, J. R., Juźwik, C. A., Benson, C. A., Monks, M. R., Harris, C. A., & Ploughman, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515601513 · Cited by 41
Mirandola, S. R., Longo, D. E. M. H., Farias, A. S., de Oliveira, E. C., Brandão, C. O., Ruocco, H. H., Damasceno, B. P., & dos Santos, L. M. B. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.03.004 · Cited by 37
Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
Li, R., Rezk, A., Li, H., Gommerman, J. L., Prat, A., & Bar-Or, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601572 · Cited by 36
Mazzola, M. A., Raheja, R., Regev, K., Beynon, V., von Glehn, F., Paul, A., Pierre, I. V., Kivisäkk, P., Weiner, H. L., & Gandhi, R. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517740213 · Cited by 34
Myeloid cells as target of fingolimod action in multiple sclerosis
Dario, M. D., Colombo, E., Govi, C., Feo, D. D., Messina, M., Romeo, M. A. L., Sangalli, F., Moiola, L., Rodegher, M., Martino, G., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000157 · Cited by 33
Navas‐Madroñal, M., Valero-Mut, A., Martínez‐Zapata, M. J., Simón-Talero, M. J., Figueroa-Bonaparte, S., Vidal, N., López‐Góngora, M., Escartín, A., & Querol, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175538 · Cited by 15
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment
Haki, M., AL-Biati, H. A., Al-Tameemi, Z. S., Ali, I. S., & Al-hussaniy, H. A. (2024) · Medicine · doi:10.1097/md.0000000000037297 · Cited by 274
White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
“On the other hand, the inflammatory environment in MS lesions initiates additional layers of complexity that exacerbate the block in OPC differentiation [133].”
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity
Tolentino, M., Pace, F., Perantie, D. C., Mikesell, R., Huecker, J., Chahin, S., Ghezzi, L., Piccio, L., & Cross, A. H. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106268 · Cited by 11
Tong, L., Ozes, B., Moss, K., Myers, M., Attia, Z., Vetter, T. A., Trapp, B. D., & Sahenk, Z. (2025) · Gene Therapy · doi:10.1038/s41434-025-00518-9 · Cited by 8
Neuroinflammation-on-a-chip for multiple sclerosis research: a narrative review
Berjaoui, C., Kachouh, C., Joumaa, S., Hussein Ghayyad, M., Abate Bekele, B., Ajirenike, R., Al Maaz, Z., Awde, S., Wojtara, M., Nazir, A., et al. (2024) · Annals of Medicine & Surgery · doi:10.1097/ms9.0000000000002231 · Cited by 4
Metadata
- Authors
- Haase, S., & Linker, R. A.
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2021-01
- Volume
- 14
- Pages
- 17562864211007687-17562864211007687
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- OpenAlex
- W3156158526
- Cited by
- 183
- References
- 162
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.